argyrotsipi/train-dataset huggingface dataset:
Psychoactive Substances Bill [HL] — House of Lords, 2015-06-23
Topic: Health
Michael Bates (Conservative, Centre-right): I certainly agree with the noble Baroness that the wider issue is not narrow, it is very broad, but what we are trying to do here with this Bill is very narrow. It is very focused and based on the evidence. The noble Baroness says that the two amendments are linked but distinct. Now she is a lawyer and I am not, but to me if they are linked then they cannot be distinct. They are linked in the sense that if they are both moved together, then one effect will be to have a review which will delay action being taken on this menace—or mischief, as the noble Lord, Lord Condon, said—which is happening up and down this country and through which people are suffering and dying. We need to take action and we are doing that on the basis of medical evidence, law enforcement evidence and evidence from the Local Government Association.
Psychoactive Substances Bill [HL] — House of Lords, 2015-06-23
Topic: Health
Michael Bates (Conservative, Centre-right): I shall come to that a little further on. The point made by the noble Lord about diamorphine, which is prescribed in this country, is perfectly fair. Interestingly, in some other countries it is not prescribed. There will be a difference of view. That is one reason why, from a government and policy point of view, it is important that we have the best possible scientific advice and give due regard to it. The advisory council is specifically charged with that under the Misuse of Drugs Act 1971; that categorisation is its view. Should there be derivatives—I shall answer my noble friend Lord Blencathra’s point on that in a minute—we have the Medicines and Healthcare Products Regulatory Agency, which can offer some advice as well. Beyond that, the National Institute for Health and Clinical Excellence can decide on the deployment. That is not a case of policymakers passing the buck but of their basing policy on the evidence that comes before them. The Government’s position, based on the advice of the Advisory Council on the Misuse of Drugs, is that cannabis in its raw form is a harmful drug and its use should not be encouraged. The advisory council has reported that there is clear evidence that cannabis has a number of acute and chronic health effects, and that prolonged use can induce dependence. Even occasional use of the drug can pose significant dangers for people with mental health problems.
Armed Forces: Capability — House of Lords, 2017-01-12
Topic: Defense
David Brownrigg Craig (Crossbench, Unknown): My Lords, it is a pleasure to follow the independent-minded noble Lord, Lord Campbell of Pittenweem. The Royal Air Force that I had the privilege to lead in the mid-1980s was close to 100,000 personnel and more than 30 combat squadrons. Today’s Chief of the Air Staff has a force of less than a third of that in personnel, and a quarter in squadrons. Yes, airframes and perhaps even people are more capable than their predecessors, but with such small numbers, they lack a key fighting quality: resilience in combat against other than a very poorly equipped or incapable foe The Army and the Royal Navy have faced similar reductions in the past 30 years in their musclepower. What, then, should the Armed Forces be expected to do? Rule out unforeseen operations of the scale or intensity fielded in 1982 to recover the Falklands, or in 1991 to throw the Iraqis out of Kuwait? Indeed, enduring operations on the scale of those in Iraq and Afghanistan are no longer feasible without strong Allied involvement. Even the more limited scale of offensive operations now in hand, mainly by the RAF, is stretching the human side of this activity Brexit adds a new dimension for the Armed Forces. We must surely maintain the many excellent military-to-military contacts we enjoy with forces in Europe and North America. The increasing vision of trade with Commonwealth and overseas partners should be matched by greater contact with their military units A good start was the recent visit by RAF Typhoon aircraft to Malaysia, Japan and South Korea, and by the successful Red Arrows displays in the Middle East and China. These deployments demonstrated operational reach and logistic support over thousands of miles. They made many new contacts and were widely noted and appreciated What is the bottom line? We lack strength in numbers. We are not well placed to deal with an inevitable unforeseen, least of all against a capable foe. The more independently minded we become, the more capability we need in a dangerous world. Surely the two must go together The first choice in threat resolution has to be soft power, whether by diplomatic, economic or other non-military means. But success in such endeavour will surely be strengthened if it is backed by well-found hard power. We do it for the ultimately adverse scenario with the nuclear deterrent. We need more conventional hard power for the rest.
Conscientious Objection (Medical Activities) Bill [HL] — House of Lords, 2018-03-23
Topic: Health
Jennifer Louise Tonge (Non-Affiliated, Unknown): Very briefly, by way of personal explanation, I hope I did not imply that people should leave the service if they were required to perform an abortion. I was saying that there are many specialties to go into in medicine. My goodness, you can do anything in medicine, from management and pen-pushing right down to—well, I will not say "down to" because it would demean whoever I got down to. There are many branches of the medical profession; there is no need to go into obstetrics and gynaecology in the knowledge that you will have to do things totally against your conscience.
Penrose Inquiry — House of Lords, 2015-03-26
Topic: Health
Frederick Richard Penn Curzon (Conservative, Centre-right): My Lords, I am grateful to the noble Lord, Lord Hunt, for his comments and questions. There is no doubt that Lord Penrose has done a very thorough job in examining the facts. It is worth understanding that he has considered the evidence from England as well as Scotland I pay tribute to those who showed tremendous courage in telling the inquiry about the impact of infection on their lives and the lives of their families. The report has systematically examined the facts and set them out. As well as other inquires, such as the Archer inquiry, with which the noble Lord is familiar, this report has now given us a detailed account of what happened, which is extremely valuable. I agree that there will be a need to reach a formal view on Penrose’s conclusions once my department and the next Government have had an opportunity properly to consider the conclusions that he reached As for Lord Penrose’s recommendation to offer a hepatitis C test to everyone who had a blood transfusion before 1991, the department conducted a look-back exercise in 1995 to try to identify everyone who might have received infected blood prior to 1991. We will consider whether anything more can be done on this in England, although obviously Lord Penrose’s recommendation relates specifically to the Scottish Government taking steps along these lines. We have already done an exercise to identify anyone who could have been affected, and we will consider whether anything more should be done on this The noble Lord asked about the Skipton Fund, which, as noble Lords will remember, is there to make non-discretionary payments to patients infected with hepatitis C. To date, over 5,100 individuals in the UK have received the stage one payment and around 1,500 have received a stage two lump sum in the UK, with around 700 receiving annual payments in the UK.
Penrose Inquiry — House of Lords, 2015-03-26
Topic: Health
Peter Fowler (Conservative, Centre-right): My Lords, I am very glad to hear the Government’s pledge to give all possible help to those who have been harmed through no fault of their own. However, with respect that pledge has been given before. It is very important this time that it is properly, and above all generously, followed through Does my noble friend agree that we should take note of Lord Penrose’s statement, following his very detailed and long inquiry, when he said yesterday: "Much of the comment made over the years on the topics discussed in the Final Report has reflected strongly-held beliefs. Some commentators believe that more could have been done to prevent infection in particular groups of patients. Careful consideration of the evidence has, however, revealed few respects in which matters could or"— more importantly— "should have been handled differently" Will my noble friend endorse that conclusion?
Penrose Inquiry — House of Lords, 2015-03-26
Topic: Health
Frederick Richard Penn Curzon (Conservative, Centre-right): My Lords, if my noble friend will forgive me, I do not want to be drawn too closely on Lord Penrose’s comments, as we should reflect on them carefully. However, it is clear that, as knowledge of these viruses began to emerge in the 1970s and early 1980s, no tests were available to screen blood donations and no means existed to inactivate the virus in blood or blood products. By 1985, a screening test for HIV was available, and heat-treated plasma products that inactivated the virus had been developed. It was not until 1990 that an effective screening test for hepatitis C was available. It is important to put that into context, because Lord Penrose found that clinicians acted in accordance with the technical facilities that they had available to them and in accordance with the ethical frameworks that were in place during the 1970s and 1980s. The ethical frameworks in which clinicians operate today are of course very different from those that were in place then.
Penrose Inquiry — House of Lords, 2015-03-26
Topic: Health
Frederick Richard Penn Curzon (Conservative, Centre-right): The noble Baroness makes a very important point. NICE guidance on the first of the new hepatitis C drugs is expected in June this year. Pending that, in April last year NHS England introduced an early access scheme for the new hepatitis C therapies. Over 700 patients have now been treated as a result of that policy, including some of those who were infected by blood or blood products in the 1970s and 1980s. NHS England is considering a further early access policy to include patients with cirrhosis, which it is aiming to have in place in the first half of this year. I think that should be of comfort to many patients.
Mental Health and NHS Performance Update — House of Lords, 2017-01-09
Topic: Health
Ajay Kakkar (Crossbench, Unknown): My Lords, I declare my interest as chairman of University College London Partners, and join others in welcoming the Minister to his new responsibilities. With regard to the current performance in accident and emergency departments, part of the explanation in the past has been the lack of access to and availability of primary care services. What thought have Her Majesty’s Government given to the potential for the provision of GP primary care services within accident and emergency departments? How is that work going forward and how might it be integrated with the broader provision of primary care services in the community?
Falkland Islands Defence Review — House of Lords, 2015-03-24
Topic: Defense
John Astor (Conservative, Centre-right): My Lords, I can assure the noble and gallant Lord that the destroyers and frigates are within a certain number of days’ sailing distance from the Falkland Islands—we are very insistent on that. I think he will agree with me that sometimes an invisible deterrent is as effective.
Standardised Packaging of Tobacco Products Regulations 2015 — House of Lords, 2015-03-16
Topic: Health
Thomas Jopling (Conservative, Centre-right): My Lords, I do not want to trump the ace of the noble Baroness, Lady Tonge, when she said that she gave up smoking in 1974 but, in 1950, at the end of my first year at university, I became very ill. I spent 12 weeks in hospital with a chest complaint—the doctors thought that it was tuberculosis, but mercifully it was not. At the end of it, the surgeon came to me—he was the professor of thoracic surgery at Newcastle, George Mason; the noble Lord, Lord Walton, will remember him. He said to me, "I think you’re going to be all right but, tell me, do you smoke?". I said yes. He said, "Well, you shouldn’t". I said, "Oh, come on. My father’s been talking to you". He said, "No, I haven’t talked to your father, but one of our students in the University at Newcastle"—it was Dr Strang, who again I think the noble Lord will recall—"has just written a thesis where he has claimed to find a connection between smoking and lung cancer. I’ve scanned it and I haven’t properly been through it, but I found it very compelling. You’ve done the first year of a science degree. You will understand not all of it but most of it, and I’ll give it to you". The following day there arrived on my bed in the hospital the thesis by this young student. I read it and I was so horrified that I have never smoked a cigarette from that day to this—I was smoking about 25 a day at that time. Ever since then, I have taken a great interest in the connection between smoking and lung cancer. I heard what the noble Lord, Lord Walton, said about the horrors of tobacco, which I thoroughly support. All the time since, I have listened to the arguments one way or another, as we have listened to the arguments here today I come back to what the noble Lord, Lord Faulkner of Worcester, said earlier about the publicity of the tobacco industry. I remember so well through the 1960s and 1970s, when I was in the other place, what I can only call the wicked advertisements, publicity and PR of the tobacco industry. I think the connection between smoking and lung cancer became clear in the 1950s, yet in the 1960s and 1970s the tobacco industry still tried to pretend that there was no danger whatever. That really was wicked I have not, I confess, examined the arguments about packaging this time but I listened to the arguments tonight. Bearing in mind the negative start I made—I admit it—when looking at the publicity of the tobacco industry, it seems that this is an experiment well worth trying. For that reason, I most strongly support the Government’s line tonight.
Higher Education and Research Bill — House of Lords, 2017-01-30
Topic: Health
Narendra Babubhai Patel (Crossbench, Unknown): My Lords, I rise briefly to support the amendment moved by the noble Lord, Lord Willis of Knaresborough, and spoken to by the noble and learned Lord, Lord Mackay of Clashfern, who covered extensively the reason why it is necessary for the charity sector to be represented on the board of UKRI. My experience during my time serving on the Medical Research Council showed that collaborations between the three major medical research charities, the Wellcome Trust, Cancer Research UK and the British Heart Foundation, made an enormous contribution. It would be rather odd if the medical research charities are not represented on a body whose job is going to be that of co-ordinating research in the entire sector across the United Kingdom. It is imperative that they should be represented, and I think that UKRI will gain from that. Again, I support the amendment.
Psychoactive Substances Bill [HL] — House of Lords, 2015-06-30
Topic: Health
Michael Bates (Conservative, Centre-right): I am grateful to the noble Lord for giving us an opportunity to look at this important area of trading standards. We expect businesses currently openly selling psychoactive substances to comply with the new law. We will be working with the police and local authorities in the lead-up to the provisions coming into force—which we aim to have happen on 1 April 2016 —to ensure that head shops and online traders operating in the UK are in no doubt that they must clear their shelves of these substances and clean up their websites by 31 March. If they do not, they can expect an early visit from the police or a local authority officer. For those who fail to comply with the law, prohibition orders will offer one possible tool with which law enforcement agencies can respond I am very much aware of the excellent work that trading standards officers do around the country. I have noticed their work many times, particularly in my former constituency, where they did tremendous work. Local authorities have overall responsibility for public health and spend around 25%—£760 million—of their health budget on dealing with drug and alcohol misuse. The introduction of the ban should reduce this expenditure, allowing councils to use funds to tackle other public health priorities. If it were the Government saying that, I would expect the noble Lord to say, "I’m not too sure about that". In fact, the LGA is saying just that. It sees this as assisting councils in focusing on the other real problems in their areas which need to be tackled. Far from incurring cost, it sees the blanket ban as easing pressure The shop in Canterbury which I keep referring to, which is just across the road from the King’s School, was closed down by trading standards and reopened under a different name. As we have said all the way through, this kind of whack-a-mole game of cat and mouse that is going on between law enforcement agencies and the purveyors of new psychoactive substances goes to the very heart of what the Bill is about.
Maternity Services in Morecambe Bay — House of Lords, 2015-03-03
Topic: Health
Frederick Richard Penn Curzon (Conservative, Centre-right): I am grateful to my noble friend and I do indeed recall our debates on the NHS Redress Act. It is telling that the previous Government chose not to bring that Act into force in the end. The recommendation in the report that there should be a fundamental review of the NHS complaints system is one that we will consider very carefully. We agree that there are still challenges to improving NHS complaints handling, including improving the culture around complaints. Those challenges have been well documented. Our work to improve complaints handling across the board was set out in our update on progress in response to the Francis inquiries in February. Complaints and how they are handled is now one of the key strands of inquiry in all inspections of the CQC On my noble friend’s point in relation to recommendation 27, the GMC, the NMC and the PSA have guidance in place on how to raise and act on concerns about patient safety. We will work with these bodies to determine whether this guidance needs strengthening in the light of this report. The GMC has been undertaking its own review of how it deals with doctors who raise concerns in the public interest On my noble friend’s final point about the disjointedness of the CQC and the Parliamentary and Health Service Ombudsman, a new MOU was signed in September 2013 which outlined how the two organisations would collaborate, co-operate and share information relating to their respective roles. It is without question that the lack of co-ordination between the CQC and the PHSO was a contributory factor to the ongoing inability of the wider system to identify and act on failings at the trust.
UK Response to the Ebola Outbreak in West Africa — House of Lords, 2015-03-12
Topic: Health
Nicholas Bourne (Conservative, Centre-right): First, my noble friend is absolutely right to pay tribute, too, to the local health workers from Sierra Leone, who obviously face the same dangers and are working tirelessly, as are our own public servants, to deal with this tragic emergency. I shall update noble Lords on the position on the spring conference. At the Brussels conference, which was referred to in the Statement, the Secretary of State again ensured that the international message is going out loud and clear. The World Health Organization has its annual meeting in May, which is another crucial date for making sure that the forward planning for dealing with such situations in future is in place. Further to that, I will respond in writing to the specific question that my noble friend asked and ensure that a copy is placed in the Library.
Misuse of Drugs Act 1971 (Temporary Class Drug) (No. 3) Order 2015 — House of Lords, 2015-12-22
Topic: Health
Sally Rachel Hamwee (Liberal Democrats, Centre to centre-left): My Lords, the House will be grateful to the Minister for managing, just about, to get through that presentation. I have one question and one request for him. My question is about the progress of the Psychoactive Substances Bill. He mentioned that it would be enacted in the new year but it seems to have become a bit stranded in the House of Commons, and I wonder whether he has any more detail than that My request relates to a completely different matter. It comes from a conversation with colleagues just outside the Chamber during the previous debate. Next time the Minister does one of his amazing walks for charity, can he tell us, as we would like to support him? I do not know whether he is going to the North Pole or the South Pole over Christmas. I prefer to think of him sitting by a fire with a big box of chocolates but I do not think that is quite his style. However, we are so impressed by what he does during recesses, when most of us slob about, that we would at least like to support him in that way.
International Development (Official Development Assistance Target) Bill — House of Lords, 2015-02-06
Topic: Health
Peter Fowler (Conservative, Centre-right): I am grateful, but not for the first time I think that Margaret Hodge is wrong. When my noble friend talks about last-minute financial juggling, he is overstating the case very substantially indeed. The reality that lies below what we have heard at the moment is that we are also talking about underresourced hospitals where drugs run out and patients die, and around the world where births are taking place on concrete floors. I know that my noble friend agrees with the point that I have just made.
International Development (Official Development Assistance Target) Bill — House of Lords, 2015-02-06
Topic: Health
Peter Fowler (Conservative, Centre-right): No, I do not think it does and for the reasons I have just stated. Untypically, I do not think that my noble friend is listening to my argument, because this has been in preparation for at least two years, to my knowledge. That cannot be denied. My noble friend talked about people not reading the reports, but he should read some of the statements made by previous Secretaries of State. It is totally unfair to talk about DfID financially juggling the figures. That is not right; it is responding to a need from around the world because there is a need for consistency. If you are going to develop a vaccine, for example, you need consistency in the money and support that come forward I will make one last point. My noble friend started his speech by saying disparagingly that this is a Liberal Democrat measure. It is a Liberal Democrat measure but it is one that is, and has been, supported by all three parties. We have a bipartisan position here. I say to my noble friends who have spoken in favour of this amendment that while that is obviously their view, which I respect—I respect my noble friend Lord MacGregor, for example, and my other colleagues—they are the minority in this debate. The majority in the other place overwhelmingly supported this provision. It would be my guess and estimate that if this ever came to a vote in this House on the principle, it would be supported here overwhelmingly in just the same way.
Commonwealth — House of Lords, 2017-03-16
Topic: Health
Shreela Flather (Crossbench, Unknown): My Lords, the CDC Group has paid a great deal of money to Narayana Health, a corporate health provider in India, but everything I have found out about it indicates that it is a very rich organisation. If it is creating jobs in India, that is not the way to do it. If it can help people who cannot afford healthcare, it is not doing it.